← FDA Drug Approvals (Drugs@FDA)

KETAMINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BAXTER HLTHCARE CORP · Approved 2025-09-17

Drug application

FDA Application #

ANDA219684

Application type

Abbreviated New Drug Application (Generic)

Brand name

KETAMINE HYDROCHLORIDE

Generic name

KETAMINE HYDROCHLORIDE

Active ingredients

KETAMINE HYDROCHLORIDE

Dosage form

SOLUTION

Route

INTRAMUSCULAR, INTRAVENOUS

Marketing status

Prescription

Sponsor

BAXTER HLTHCARE CORP

Manufacturer

Baxter Healthcare Corporation

First approval

2025-09-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown